Stock Market Regulatory conditions on Novo Holdings’ $16.5 billion Catalent deal fulfilled, companies say By ReutersDecember 23, 20240 (Reuters) – Novo Holdings’ $16.5 billion acquisition of U.S. contract drug maker Catalent is set to be completed in the…
